Many foods are often advertised for their antioxidant properties. Antioxidants counteract what are known as reactive oxygen ...
January's FDA oncology approvals offer new treatment options for breast cancer, mantle cell lymphoma, and other malignancies.
Here is a select list of cancer therapies approved by the FDA throughout the month of January, featuring patient populations ...
Several companies—including JCR Pharmaceuticals, Denali Therapeutics and Regenxbio— have products in the pipeline that could ...
The global cell separation market size was valued at USD 9.74 billion in 2024 and is projected to reach from USD 10.69 ...
Featured data showcase the transformative potential of HSC gene therapy to enable cross-correction and restore enzymatic ...
"With the global stem cell market expanding, we see an opportunity to make these treatments more accessible in the U.S.," ...
PRINCETON, N.J., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), today announced that two oral presentations and 20 posters across its development programs will be included at ...
A study finds that shared care between HCT specialists and local oncologists improves early quality of life without ...
在骨髓中,myHSCs和淋巴系造血干细胞(lyHSCs)的数量对比进一步显示了Sema4A缺失对髓系细胞的过度偏向(g、h)。特别是髓系前体细胞(MyPro)和红系前体细胞(CFU-E)的数量变化,也支持了Sema4A缺失与髓系扩展的关系。
This valuable study presents a mouse gastruloid model that can be used to generate hematopoietic progenitors as well as leukemic cells. However, in its current form, the manuscript is inadequate ...